Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO effects on pulmonary vascular parameters in PAH
NCT02734953Phase 2Completed
- Sponsor
- Allegheny Singer Research Institute
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in pulmonary arterial hypertension (PAH), sponsored by Allegheny Singer Research Institute. Started Apr 2016; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02734953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734953.